Elacestrant Market Size, Forecast, and Emerging Insight

ha aggiunto una foto Health

2025-01-13 10:42:31 -

Elacestrant Market Size, Forecast, and Emerging Insight – 2032

Elacestrant, a selective estrogen receptor degrader (SERD), is rapidly emerging as a promising treatment option in the oncology market, particularly for hormone receptor-positive (HR+), HER2-negative breast cancer. As a targeted therapy, Elacestrant works by binding to estrogen receptors and promoting their degradation, which helps inhibit cancer cell growth. This article...

0 Commenti 0 condivisioni 22 Views 0 Anteprima